These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21836028)

  • 1. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
    Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
    Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
    Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
    Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
    Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
    Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary and alternative medicine in patients with inflammatory bowel disease: results of a cross-sectional study in Norway.
    Opheim R; Bernklev T; Fagermoen MS; Cvancarova M; Moum B
    Scand J Gastroenterol; 2012 Dec; 47(12):1436-47. PubMed ID: 23003678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
    Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
    Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease.
    Rawsthorne P; Shanahan F; Cronin NC; Anton PA; Löfberg R; Bohman L; Bernstein CN
    Am J Gastroenterol; 1999 May; 94(5):1298-303. PubMed ID: 10235210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services.
    Sirois FM
    Complement Ther Med; 2008 Apr; 16(2):73-80. PubMed ID: 18514908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in fatigue over 2 years are associated with activity of inflammatory bowel disease and psychological factors.
    Graff LA; Clara I; Walker JR; Lix L; Carr R; Miller N; Rogala L; Bernstein CN
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1140-6. PubMed ID: 23602816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
    Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
    Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
    Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
    Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Manitoba Inflammatory Bowel Disease Cohort Study: prolonged symptoms before diagnosis--how much is irritable bowel syndrome?
    Burgmann T; Clara I; Graff L; Walker J; Lix L; Rawsthorne P; McPhail C; Rogala L; Miller N; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 May; 4(5):614-20. PubMed ID: 16630762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary medicine use in children and young adults with inflammatory bowel disease.
    Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
    Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
    Sirois FM
    Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?
    Burgmann T; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2004 May; 99(5):889-93. PubMed ID: 15128356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
    Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls.
    Graff LA; Walker JR; Clara I; Lix L; Miller N; Rogala L; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2009 Dec; 104(12):2959-69. PubMed ID: 19755973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.
    Day AS; Whitten KE; Bohane TD
    J Paediatr Child Health; 2004 Dec; 40(12):681-4. PubMed ID: 15569284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life.
    Graff LA; Walker JR; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; Jakul L; McPhail C; Ediger J; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1491-1501. PubMed ID: 17162241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
    Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
    J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Clin Gastroenterol Hepatol; 2008 Jan; 6(1):41-5. PubMed ID: 18063423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.